Sirio Pharma Co., Ltd. (SHE:300791)

Market Cap	6.50B +0.8%
Revenue (ttm)	4.45B +7.9%
Net Income	345.53M +2.9%
EPS	1.13 +2.7%
Shares Out	305.96M
PE Ratio	18.77
Forward PE	26.73
Dividend	0.50 (2.35%)
Ex-Dividend Date	May 27, 2025

Volume	2,899,314
Average Volume	2,197,792
Open	20.39
Previous Close	21.44
Day's Range	20.39 - 21.86
52-Week Range	18.50 - 28.19
Beta	0.34
RSI	54.31
Earnings Date	Apr 24, 2026

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1993
• Employees: 2,776
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300791

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.